Earnings Outlook For ImmunoPrecise Antibodies

ImmunoPrecise Antibodies IPA is set to give its latest quarterly earnings report on Thursday, 2023-03-16. Here's what investors need to know before the announcement.

Analysts estimate that ImmunoPrecise Antibodies will report an earnings per share (EPS) of $-0.17.

ImmunoPrecise Antibodies bulls will hope to hear the company announce they've not only beaten that estimate, but also to provide positive guidance, or forecasted growth, for the next quarter.

New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).

Here's a look at ImmunoPrecise Antibodies's past performance and the resulting price change:

Stock Performance

Shares of ImmunoPrecise Antibodies were trading at $3.89 as of March 14. Over the last 52-week period, shares are down 10.87%. Given that these returns are generally negative, long-term shareholders are likely a little upset going into this earnings release.

To track all earnings releases for ImmunoPrecise Antibodies visit their earnings calendar on our site.

This article was generated by Benzinga's automated content engine and reviewed by an editor.